Health Claims
Consumers looking to improve their health need to be wary of deceptive marketing.
Unsubstantiated health claims are made by many different types of companies, including supplement retailers, MLMs and device makers.
Consumers looking to improve their health need to be wary of deceptive marketing.
Seen or heard a deceptive ad? Report an Ad
TINA.org submitted a comment to the FTC supporting a proposed consent order reached in a case the agency filed against TruHeight alleging deceptive growth claims and fabricated reviews.
TINA.org found supplement company claiming its product could improve memory without having the necessary competent or reliable scientific evidence.
TINA.org investigation found company using unsubstantiated health and disease-treatment claims to market many of its products.
Lisa Fickenscher, New York Post
Sara Talpos, Med Shadow
Sarah Todd, STAT News
What were these adult skincare products doing in this 13+ Roblox experience?
Information about relevant class actions filed around the country.
Bodywell cellphone chips
Falsely advertising that products provide various health benefits – including that they reduce the amount of radiation that a brain absorbs by 80 percent and the temperature of a brain by 50 percent; reduce headaches, hand pain and anxiety; and improve sleep quality and mental clarity – when the products do not provide any of the advertised benefits
Pending
Hoffman et al. v. Haim Einhorn et al.
26-cv-1414, D.N.J.
(Jan. 2026)
Bodywell cellphone chips
Falsely advertising that products provide various health benefits – including that they reduce the amount of radiation that a brain absorbs by 80 percent and the temperature of a brain by 50 percent; reduce headaches, hand pain and anxiety; and improve sleep quality and mental clarity – when the products do not provide any of the advertised benefits
Pending
Crest Pro-Health toothpastes
Falsely marketing that products improve gum health and treat gingivitis when the sodium lauryl sulfate in them can cause gum and mouth tissue damage, inflammation, allergic reactions and other oral health conditions
Pending
Oliver et al. v. The Procter & Gamble Co.
26-cv-3859, S.D. Cal.
(July 2026)
Crest Pro-Health toothpastes
Falsely marketing that products improve gum health and treat gingivitis when the sodium lauryl sulfate in them can cause gum and mouth tissue damage, inflammation, allergic reactions and other oral health conditions
Pending
Colgate Total toothpastes
Falsely marketing that products improve gum health and treat gingivitis when the sodium lauryl sulfate in them can cause gum and mouth tissue damage, inflammation, allergic reactions, and other oral health conditions
Pending
Walsh et al. v. The Colgate-Palmolive Co.
26-cv-3858, S.D. Cal.
(July 2026)
Colgate Total toothpastes
Falsely marketing that products improve gum health and treat gingivitis when the sodium lauryl sulfate in them can cause gum and mouth tissue damage, inflammation, allergic reactions, and other oral health conditions
Pending
Sensodyne and Parodontax toothpastes
Falsely marketing that products improve gum health and treat gingivitis when the sodium lauryl sulfate in them can cause gum and mouth tissue damage, inflammation, allergic reactions, and other oral health conditions
Pending
Garland et al. v. Haleon US, Inc.
26-cv-3855, S.D. Cal.
(July 2026)
Sensodyne and Parodontax toothpastes
Falsely marketing that products improve gum health and treat gingivitis when the sodium lauryl sulfate in them can cause gum and mouth tissue damage, inflammation, allergic reactions, and other oral health conditions
Pending
Amaral et al. v. Chattem Inc. d/b/a Opella North America and Sanofi-Aventis U.S. LLC
26-cv-5474, N.D. Cal.
(June 2026)
Unisom SleepGels, PM Pain, SleepMinis
Falsely marketing products as “non-habit forming” when their active ingredient (diphenhydramine HCI) can lead to dependence and abuse
Pending
Amaral et al. v. Chattem Inc. d/b/a Opella North America and Sanofi-Aventis U.S. LLC
26-cv-5474, N.D. Cal.
(June 2026)
Unisom SleepGels, PM Pain, SleepMinis
Falsely marketing products as “non-habit forming” when their active ingredient (diphenhydramine HCI) can lead to dependence and abuse
Pending